Biodelivery Sciences International Inc
BDSIDelisted Mar 22, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001103021
Biodelivery Sciences International Inc was delisted on Mar 22, 2022; its insiders filed their last Form 4 on Mar 22, 2022; 156 institutions reported holding it in 13F filings for Q4 2021, worth $181.5M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 156
- Q4 2021, +5 vs. previous quarter
- 13F value
- $181.5M
- Reported value at the end of Q4 2021
- Superinvestors holding
- 0
- At the end of Q4 2021
Superinvestors holding BDSI, Q4 2021
No superinvestor reported holding BDSI at the end of Q4 2021.
Latest insider trades
Open-market purchases and sales by Biodelivery Sciences International Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2022 (view filing) | Feb 4 | 4 days | Vollins JamesSee Remarks | SSale | −18.5K | $3.60 | −$66.7K | −65.3%9.87K after | |
| Dec 6, 2021 (view filing) | Dec 2 | 4 days | Sirgo Mark ADirector | PPurchase | +18.6K | $2.69 | +$50.0K | +1.6%1.16M after | |
| Nov 22, 2021 (view filing)7:37 AM ET | Nov 19 | 3 days | Broadfin Healthcare Master Fund Ltd and 2 othersDirector | PPurchase | +100.0K | $3.06 | +$306.0K | +2.0%5.16M after | |
| Nov 19, 2021 (view filing) | Nov 18 | 1 day | Sirgo Mark ADirector | PPurchase | +10.0K | $3.04 | +$30.4K | +0.9%1.14M after | Amended |
| Nov 15, 2021 (view filing)7:56 AM ET | Nov 12 | 3 days | Broadfin Healthcare Master Fund Ltd and 2 othersDirector | PPurchase | +100.0K | $3.20 | +$320.0K | +2.0%5.06M after | |
| Nov 12, 2021 (view filing) | Nov 11 | 1 day | Sirgo Mark ADirector | PPurchase | +16.0K | $3.20 | +$51.2K | +1.4%1.13M after | |
| Nov 9, 2021 (view filing)10:28 AM ET | Nov 5 | 4 days | Broadfin Healthcare Master Fund Ltd and 2 othersDirector | PPurchase | +257.8K | $3.47 | +$894.6K | +5.5%4.96M after |
Top 10 13F holders, Q4 2021
The largest institutional positions in Biodelivery Sciences International Inc at the end of Q4 2021; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 7,305,512 | $22.6M | 0.00% | −282,970−3.7% | Reduced |
| Vanguard Group Inc | 4,742,364 | $14.7M | 0.00% | +35,313+0.8% | Added |
| Systematic Financial Management LP | 4,339,837 | $13.5M | 0.40% | +312,552+7.8% | Added |
| LSV Asset Management | 3,514,945 | $10.9M | 0.02% | +1,590,545+82.7% | Added |
| Royce & Associates LP | 2,406,069 | $7.46M | 0.06% | +815,418+51.3% | Added |
| Wasatch Advisors Inc | 2,254,592 | $6.99M | 0.03% | −3,160,555−58.4% | Reduced |
| Magnetar Financial LLC | 2,178,062 | $6.75M | 0.07% | +1,672,320+330.7% | Added |
| State Street Corp | 2,021,178 | $6.27M | 0.00% | −126,214−5.9% | Reduced |
| Rubric Capital Management LP | 1,747,401 | $5.42M | 0.26% | +1,747,401 | New |
| Geode Capital Management, LLC | 1,724,411 | $5.34M | 0.00% | −24,223−1.4% | Reduced |